Edwyn
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | $16,471 | $17,421 | $17,967 | $19,457 | $20,101 |
| Gross Profit | $10,017 | $10,375 | $10,248 | $11,326 | $12,161 |
| Operating Income | $3,885 | $3,332 | $2,893 | $3,984 | $4,268 |
| Net Income | $2,695 | $2,166 | $1,785 | $2,300 | $2,889 |
Over the five-year period, Colgate-Palmolive’s revenue increased steadily from USD 16,471 million in 2020 to USD 20,101 million in 2024, signaling overall top-line growth of about 22%. Gross profit also trended upward, rising from USD 10,017 million in 2020 to USD 12,161 million in 2024, despite a slight dip in 2022 where gross profit decreased marginally from USD 10,375 million in 2021 to USD 10,248 million. Operating income experienced fluctuations—with an initial drop from USD 3,885 million in 2020 to USD 3,332 million in 2021, followed by a rebound to USD 4,268 million in 2024—indicating variations that may reflect periodic operational adjustments or cost pressures. While no single year's revenue or operating income change exceeded a 20% swing, the sequential decline in net income is notable: net income dropped approximately 34% from USD 2,695 million in 2020 to USD 1,785 million in 2022, before recovering to USD 2,889 million in 2024. This resurgence in net income, along with steady increases in revenue and gross profit, underscores Colgate-Palmolive’s resilience within the highly competitive consumer goods sector. The company’s ability to rebound from earlier declines suggests effective strategies in managing costs and potentially capitalizing on market demand for essential personal care products. Overall, these metrics indicate a robust financial health and sustainability profile, bolstered by consistent revenue growth and a return to improved profitability in recent years.
This analysis is for informational purposes only and does not constitute financial advice or recommendations for any investment decisions. Please consult with a qualified financial professional for personalized guidance.